Literature DB >> 32203265

Is chronic lymphocytic leukemia curable? A clinical case relapsing 21 years after allogeneic stem-cell transplantation.

M Rovira1, N Villamor2, F Cobo3, F Fernández-Aviles1, M L López-Guerra2, F Guijarro2, T Baumann1, E Montserrat4,5,6.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32203265     DOI： 10.1038/s41409-020-0861-1

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial.

Authors:  Isabelle Krämer; Stephan Stilgenbauer; Sascha Dietrich; Sebastian Böttcher; Matthias Zeis; Michael Stadler; Jörg Bittenbring; Lutz Uharek; Christof Scheid; Ute Hegenbart; Anthony Ho; Michael Hallek; Michael Kneba; Norbert Schmitz; Hartmut Döhner; Peter Dreger
Journal:  Blood       Date:  2017-07-17       Impact factor: 22.113

Review 2.  High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies.

Authors:  Peter Dreger; Paolo Ghia; Johannes Schetelig; Michel van Gelder; Eva Kimby; Mauricette Michallet; Carol Moreno; Tadeusz Robak; Stephan Stilgenbauer; Emili Montserrat
Journal:  Blood       Date:  2018-07-11       Impact factor: 22.113

3.  Allogeneic transplantation for high-risk chronic lymphocytic leukemia-a summary of a 16-year experience.

Authors:  Grzegorz Helbig; Adrianna Spałek; Agata Wieczorkiewicz-Kabut; Mirosław Markiewicz; Małgorzata Kopera; Patrycja Zielińska; Krzysztof Woźniczka; Anna Kopińska; Iwona Grygoruk-Wiśniowska; Anna Koclęga
Journal:  Ann Hematol       Date:  2019-03-27       Impact factor: 3.673
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.